Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1

[1]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[2]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[3]  A. Al-Chalabi,et al.  The risk to relatives of patients with sporadic amyotrophic lateral sclerosis , 2011, Brain : a journal of neurology.

[4]  C. Lewis,et al.  Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease , 2011, Human Heredity.

[5]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[6]  A. Al-Chalabi,et al.  Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[7]  Sonja W. Scholz,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2010, Neuron.

[8]  David Heckerman,et al.  Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study , 2010, The Lancet Neurology.

[9]  A. Farmer,et al.  Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study , 2010, The Lancet Neurology.

[10]  A. Al-Chalabi,et al.  An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  L. Goldstein,et al.  The sex ratio in amyotrophic lateral sclerosis: A population based study , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[12]  Janel O. Johnson,et al.  Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients , 2010, Proceedings of the National Academy of Sciences.

[13]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[14]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[15]  Luigi Ferrucci,et al.  Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain , 2010, PLoS genetics.

[16]  O. Hardiman,et al.  Familial aggregation in amyotrophic lateral sclerosis , 2010, Annals of neurology.

[17]  P. Andersen,et al.  Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[18]  C. Armon.  Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.

[19]  Ewout J N Groen,et al.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.

[20]  R. Ophoff,et al.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[21]  Sonja W. Scholz,et al.  A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[22]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[23]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[24]  A. Morris,et al.  Thioredoxin reductase 1 haplotypes modify familial amyotrophic lateral sclerosis onset. , 2009, Free radical biology & medicine.

[25]  O. Hardiman,et al.  Aggregation of neurodegenerative disease in ALS kindreds , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[26]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[27]  A. Chiò,et al.  Prevalence of SOD1 mutations in the Italian ALS population , 2008, Neurology.

[28]  Ammar Al-Chalabi,et al.  ALSOD: The Amyotrophic Lateral Sclerosis Online Database , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[29]  Orla Hardiman,et al.  A genome-wide association study of sporadic ALS in a homogenous Irish population. , 2007, Human molecular genetics.

[30]  Frank Baas,et al.  Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.

[31]  E. Beghi,et al.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[32]  R. Ophoff,et al.  ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.

[33]  Kuixing Zhang,et al.  Whole-genome analysis of sporadic amyotrophic lateral sclerosis. , 2007, The New England journal of medicine.

[34]  P. Sham,et al.  Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality , 2007, Neurogenetics.

[35]  Sonja W. Scholz,et al.  Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.

[36]  V. Meininger,et al.  Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. , 2007, Archives of neurology.

[37]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[38]  E. Beghi,et al.  Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population‐based study in southern Italy , 2006, European journal of neurology.

[39]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. , 2006, Journal of neurology.

[40]  E. Beghi,et al.  Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[42]  J. Haines,et al.  Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis , 2004, Neurogenetics.

[43]  P. Worms.  The epidemiology of motor neuron diseases: a review of recent studies , 2001, Journal of the Neurological Sciences.

[44]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.

[45]  J. Haines,et al.  Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis , 1998, Neurogenetics.

[46]  T. Usdin,et al.  A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[47]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[48]  H J Bennett,et al.  How common is common? , 1991, Southern medical journal.